Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM
Sponsor: Pfizer
Summary
This study is designed to test how well once-weekly MET097 (an ultra-long-acting GLP-1 receptor agonist) works to treat adults with obesity or overweight and type 2 diabetes mellitus (T2DM) compared to placebo. MET097 or placebo will be administered to individuals via subcutaneous injection once weekly for 28 weeks. If an individual is randomly assigned to MET097 they will receive one of four different dose regimens.
Official title: A Phase 2b, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight, and Type 2 Diabetes Mellitus (VESPER-2)
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
133
Start Date
2025-03-14
Completion Date
2026-03-18
Last Updated
2026-05-29
Healthy Volunteers
No
Interventions
MET097 Injection
MET097 is an ultra-long-acting, fully-biased analog of human GLP-1.
Placebo
Sterile 0.9% (w/v) saline will be used as placebo treatment during the study.
Locations (29)
KUR Research
Bessemer, Alabama, United States
ProSciento, Inc.
Chula Vista, California, United States
Michael Roberts Opthamologist (Eye Exam)
Glendale, California, United States
Eye Treatment Center
Long Beach, California, United States
Collaborative Neuroscience Research, LLC
Los Alamitos, California, United States
Velocity Clinical Research, Los Angeles
Los Angeles, California, United States
Clinical Innovations, Inc dba CITrials
Riverside, California, United States
Synergy Healthcare
Bradenton, Florida, United States
Miami Eye Institute
Hollywood, Florida, United States
Research Centers of America
Hollywood, Florida, United States
ForCare Clinical Research
Tampa, Florida, United States
CenExel iResearch, LLC
Decatur, Georgia, United States
EmVenio Research Centre at PRIME Healthcare
Riverdale, Georgia, United States
CenExel iResearch, LLC
Savannah, Georgia, United States
Koch Family Medicine Clinical Research
Morton, Illinois, United States
Bioluminux Clinical Research
Naperville, Illinois, United States
EmVenio Research Centre at PRIME Healthcare
Kansas City, Kansas, United States
Eagle Eye Care
Columbia, Maryland, United States
KUR Research, LLC
Columbia, Maryland, United States
CBH Health, LLC.
Gaithersburg, Maryland, United States
Emvenio Research
Garden City, Michigan, United States
Velocity Clinical Research
Omaha, Nebraska, United States
Advocare Berlin Medical Associates
Berlin, New Jersey, United States
Hassman Research Institute
Marlton, New Jersey, United States
Onsite Clinical Solutions, LLC (Satellite site)
Charlotte, North Carolina, United States
Onsite Clinical Solutions, LLC
Charlotte, North Carolina, United States
EmVenio Research Centre at PRIME Healthcare
Farmers Branch, Texas, United States
Research Your Health
Plano, Texas, United States
Revival Research Institute, LLC
Sherman, Texas, United States